Zusammenfassung
Ein 63-jähriger, im Alltag körperlich aktiver Patient stellte sich zur Abklärung von Schmerzen im mittleren Rücken und Oberbauch sowie eines ausgeprägten Gewichtsverlusts von 9 kg innerhalb von 6 Monaten auf 74 kg bei 178 cm Körpergröße (BMI 23,36 kg/m2) bei seinem Hausarzt vor.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Cannabis-In-Cachexia-Study-Group, Strasser F, Luftner D, et al. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. J Clin Oncol 2006;24:3394–3400.
Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011;364:1817–1825.
Davis MP. Cannabinoids for symptom management and cancer therapy: the evidence. J Natl Compr Canc Netw 2016;14:915–922.
Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980;69:491–497.
Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011;12:489–495.
Heigener D, Gottfried M, Bennouna J, et al. Efficacy and safety of nintedanib/docetaxel in patients with lung adenocarcinoma: further analyses from the LUME-Lung 1 study. In: ESMO: Copenhagen 2016.
Herbst RS, Baas P, Kim DW, et al. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. Lancet 2015;387:1540–1550.
Klein S, Simes J, Blackburn GL.Total parenteral nutrition and cancer clinical trials. Cancer 1986;58:1378–1386.
Kraft M, Kraft K, Gärtner S, et al. L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) – a randomized multicentre trial. Nutr J 2012;11:52.
Lundholm K, Daneryd P, Bosaeus I, et al. Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: Effects on survival, metabolism, and function. Cancer 2004;100:1967–1977.
Lundholm K, Daneryd P, Korner U, et al. Evidence that long-term COX-treatment improves energy homeostasis and body composition in cancer patients with progressive cachexia. Int J Oncol 2004;24:505–512.
Lundholm K, Gelin J, Hyltander A et al. Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res 1994;54:5602–5606.
Madeddu C, Dessì M, Panzone F, Serpe R, Antoni G, Cau MC, Montaldo L, Mela Q, Mura M, Astara G, Tanca FM, Macciò A, Mantovani G. Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome. Clin Nutr 2012;31:176–82.
Narsale AA, Carson JA. Role of interleukin-6 in cachexia: therapeutic implications. Current opinion in supportive and palliative care 2014;8:321–327.
Reck M, Von PJ, Zatloukal P, et al. Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil. J Clin Oncol 2009;27:1227–1234.
Ross PJ, Ashley S, Norton A et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer 2004; 90:1905–1911.
Sandler A, Gray R, Perry MC, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 2006;355:2542–2550.
Temel JS, Abernethy AP, Currow DC, et al. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol 2016;17:519–531.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Medizin Verlag GmbH, München
About this chapter
Cite this chapter
König, A., König, U., Heigener, D. (2017). Fälle aus der Praxis. In: Kachexie bei Tumorerkrankungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-89935-305-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-89935-305-1_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-89935-304-4
Online ISBN: 978-3-89935-305-1
eBook Packages: Medicine (German Language)